MedPath
NMPA Approval

Repaglinide Tablets

国药准字H20223711

September 30, 2022

Drug Information

瑞格列奈片

片剂

1.0mg

化学药品

September 30, 2022

Company Information

Applicant Company

吉林省通化县东宝新村

Manufacturing Company

吉林省通化县东宝新村

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

瑞格列奈片 - NMPA 批准文号 | MedPath